Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.

Patient preference and adherence

Hanson KA, Agashivala N, Stringer SM, Balantac Z, Brandes DW.
PMID: 23620662
Patient Prefer Adherence. 2013 Apr 16;7:309-18. doi: 10.2147/PPA.S41992. Print 2013.

BACKGROUND: Fingolimod is the first oral disease-modifying therapy indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses and delay the progression of physical disability caused by MS.OBJECTIVE: To...

Cite
Hanson KA, Agashivala N, Stringer SM, et al. A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod. Patient Prefer Adherence. 2013;7:309-18doi: 10.2147/PPA.S41992.
Hanson, K. A., Agashivala, N., Stringer, S. M., Balantac, Z., & Brandes, D. W. (2013). A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod. Patient preference and adherence, 7309-18. https://doi.org/10.2147/PPA.S41992
Hanson, Kristin A, et al. "A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod." Patient preference and adherence vol. 7 (2013): 309-18. doi: https://doi.org/10.2147/PPA.S41992
Hanson KA, Agashivala N, Stringer SM, Balantac Z, Brandes DW. A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod. Patient Prefer Adherence. 2013 Apr 16;7:309-18. doi: 10.2147/PPA.S41992. Print 2013. PMID: 23620662; PMCID: PMC3633540.
Copy Download .nbib Format: NLM
Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System.

BMC research notes

Malkov VA, Serikawa KA, Balantac N, Watters J, Geiss G, Mashadi-Hossein A, Fare T.
PMID: 19426535
BMC Res Notes. 2009 May 09;2:80. doi: 10.1186/1756-0500-2-80.

BACKGROUND: We assessed NanoString's nCounter Analysis System for its ability to quantify gene expression of forty-eight genes in a single reaction with 100 ng of total RNA or an equivalent amount of tissue lysate. In the nCounter System, multiplexed...

Cite
Malkov VA, Serikawa KA, Balantac N, et al. Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System. BMC Res Notes. 2009;2:80doi: 10.1186/1756-0500-2-80.
Malkov, V. A., Serikawa, K. A., Balantac, N., Watters, J., Geiss, G., Mashadi-Hossein, A., & Fare, T. (2009). Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System. BMC research notes, 280. https://doi.org/10.1186/1756-0500-2-80
Malkov, Vladislav A, et al. "Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System." BMC research notes vol. 2 (2009): 80. doi: https://doi.org/10.1186/1756-0500-2-80
Malkov VA, Serikawa KA, Balantac N, Watters J, Geiss G, Mashadi-Hossein A, Fare T. Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter Assay System. BMC Res Notes. 2009 May 09;2:80. doi: 10.1186/1756-0500-2-80. PMID: 19426535; PMCID: PMC2688518.
Copy Download .nbib Format: NLM
The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Gelhorn H, Balantac Z, Shinde S, Thieu VT, Boye KS.
PMID: 34043162
Diabetes Ther. 2021 Jul;12(7):1821-1837. doi: 10.1007/s13300-021-01054-6. Epub 2021 May 27.

INTRODUCTION: Type 2 diabetes (T2D) is extremely burdensome to people with T2D and associated with impaired health-related quality of life. This study explores the impact of T2D and potentially relevant outcomes for new therapies using a unique approach to...

Cite
Gelhorn H, Balantac Z, Shinde S, et al. The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective. Diabetes Ther. 2021;12(7):1821-1837doi: 10.1007/s13300-021-01054-6.
Gelhorn, H., Balantac, Z., Shinde, S., Thieu, V. T., & Boye, K. S. (2021). The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(7), 1821-1837. https://doi.org/10.1007/s13300-021-01054-6
Gelhorn, Heather, et al. "The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,7 (2021): 1821-1837. doi: https://doi.org/10.1007/s13300-021-01054-6
Gelhorn H, Balantac Z, Shinde S, Thieu VT, Boye KS. The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective. Diabetes Ther. 2021 Jul;12(7):1821-1837. doi: 10.1007/s13300-021-01054-6. Epub 2021 May 27. PMID: 34043162; PMCID: PMC8155797.
Copy Download .nbib Format: NLM
Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association

Kalantar Z, Sotoudeh G, Esmaeily Z, Rafiee M, Koohdani F.
PMID: 34908197
J Hum Nutr Diet. 2021 Dec 14; doi: 10.1111/jhn.12958. Epub 2021 Dec 14.

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a multidimensional consequence of environmental and genetic factors. Cholesteryl ester transfer protein (CETP) Taq1B polymorphism has been reported as a main predictor of dyslipidaemia, comprising an important complication in persons with T2DM....

Cite
Kalantar Z, Sotoudeh G, Esmaeily Z, et al. Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes. J Hum Nutr Diet. 2021;doi: 10.1111/jhn.12958.
Kalantar, Z., Sotoudeh, G., Esmaeily, Z., Rafiee, M., & Koohdani, F. (2021). Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, . https://doi.org/10.1111/jhn.12958
Kalantar, Zahra, et al. "Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes." Journal of human nutrition and dietetics : the official journal of the British Dietetic Association vol. (2021). doi: https://doi.org/10.1111/jhn.12958
Kalantar Z, Sotoudeh G, Esmaeily Z, Rafiee M, Koohdani F. Interaction between CETP Taq1B polymorphism and HEI, DQI and DPI on metabolic biomarkers in patients with type 2 diabetes. J Hum Nutr Diet. 2021 Dec 14; doi: 10.1111/jhn.12958. Epub 2021 Dec 14. PMID: 34908197.
Copy Download .nbib Format: NLM
Pd nanoparticles for C-C coupling reactions.

Chemical Society reviews

Balanta A, Godard C, Claver C.
PMID: 21879073
Chem Soc Rev. 2011 Oct;40(10):4973-85. doi: 10.1039/c1cs15195a. Epub 2011 Aug 30.

The catalytic formation of C-C bonds is one of the most useful transformations in organic synthesis. Over the last decade, the use of transition metal nanoparticles (NPs) in catalysis has attracted much interest and their use in C-C bond...

Cite
Balanta A, Godard C, Claver C. Pd nanoparticles for C-C coupling reactions. Chem Soc Rev. 2011;40(10):4973-85doi: 10.1039/c1cs15195a.
Balanta, A., Godard, C., & Claver, C. (2011). Pd nanoparticles for C-C coupling reactions. Chemical Society reviews, 40(10), 4973-85. https://doi.org/10.1039/c1cs15195a
Balanta, Angelica, et al. "Pd nanoparticles for C-C coupling reactions." Chemical Society reviews vol. 40,10 (2011): 4973-85. doi: https://doi.org/10.1039/c1cs15195a
Balanta A, Godard C, Claver C. Pd nanoparticles for C-C coupling reactions. Chem Soc Rev. 2011 Oct;40(10):4973-85. doi: 10.1039/c1cs15195a. Epub 2011 Aug 30. PMID: 21879073.
Copy Download .nbib Format: NLM
Patient and physician preferences for attributes of biologic medications for severe asthma.

Patient preference and adherence

Gelhorn HL, Balantac Z, Ambrose CS, Chung YN, Stone B.
PMID: 31440040
Patient Prefer Adherence. 2019 Jul 25;13:1253-1268. doi: 10.2147/PPA.S198953. eCollection 2019.

OBJECTIVE: Despite the increased availability of biologic treatments indicated for severe asthma, patient and physician preferences for these medications remains largely unknown. The purpose of this study was to understand perceptions of biologic therapies, barriers to care with biologic...

Cite
Gelhorn HL, Balantac Z, Ambrose CS, et al. Patient and physician preferences for attributes of biologic medications for severe asthma. Patient Prefer Adherence. 2019;13:1253-1268doi: 10.2147/PPA.S198953.
Gelhorn, H. L., Balantac, Z., Ambrose, C. S., Chung, Y. N., & Stone, B. (2019). Patient and physician preferences for attributes of biologic medications for severe asthma. Patient preference and adherence, 131253-1268. https://doi.org/10.2147/PPA.S198953
Gelhorn, Heather L, et al. "Patient and physician preferences for attributes of biologic medications for severe asthma." Patient preference and adherence vol. 13 (2019): 1253-1268. doi: https://doi.org/10.2147/PPA.S198953
Gelhorn HL, Balantac Z, Ambrose CS, Chung YN, Stone B. Patient and physician preferences for attributes of biologic medications for severe asthma. Patient Prefer Adherence. 2019 Jul 25;13:1253-1268. doi: 10.2147/PPA.S198953. eCollection 2019. PMID: 31440040; PMCID: PMC6667349.
Copy Download .nbib Format: NLM
Temporally adaptive acoustic sampling to maximize detection across a suite of focal wildlife species.

Ecology and evolution

Balantic C, Donovan T.
PMID: 31632648
Ecol Evol. 2019 Aug 22;9(18):10582-10600. doi: 10.1002/ece3.5579. eCollection 2019 Sep.

Acoustic recordings of the environment can produce species presence-absence data for characterizing populations of sound-producing wildlife over multiple spatial scales. If a species is present at a site but does not vocalize during a scheduled audio recording survey, researchers...

Cite
Balantic C, Donovan T. Temporally adaptive acoustic sampling to maximize detection across a suite of focal wildlife species. Ecol Evol. 2019;9(18):10582-10600doi: 10.1002/ece3.5579.
Balantic, C., & Donovan, T. (2019). Temporally adaptive acoustic sampling to maximize detection across a suite of focal wildlife species. Ecology and evolution, 9(18), 10582-10600. https://doi.org/10.1002/ece3.5579
Balantic, Cathleen, and Donovan, Therese. "Temporally adaptive acoustic sampling to maximize detection across a suite of focal wildlife species." Ecology and evolution vol. 9,18 (2019): 10582-10600. doi: https://doi.org/10.1002/ece3.5579
Balantic C, Donovan T. Temporally adaptive acoustic sampling to maximize detection across a suite of focal wildlife species. Ecol Evol. 2019 Aug 22;9(18):10582-10600. doi: 10.1002/ece3.5579. eCollection 2019 Sep. PMID: 31632648; PMCID: PMC6787958.
Copy Download .nbib Format: NLM
Amine Catalysis for the Organocatalytic Diboration of Challenging Alkenes.

Chemistry (Weinheim an der Bergstrasse, Germany)

Farre A, Soares K, Briggs RA, Balanta A, Benoit DM, Bonet A.
PMID: 27723203
Chemistry. 2016 Dec 05;22(49):17552-17556. doi: 10.1002/chem.201603979. Epub 2016 Oct 26.

The generation of in situ sp

Cite
Farre A, Soares K, Briggs RA, et al. Amine Catalysis for the Organocatalytic Diboration of Challenging Alkenes. Chemistry. 2016;22(49):17552-17556doi: 10.1002/chem.201603979.
Farre, A., Soares, K., Briggs, R. A., Balanta, A., Benoit, D. M., & Bonet, A. (2016). Amine Catalysis for the Organocatalytic Diboration of Challenging Alkenes. Chemistry (Weinheim an der Bergstrasse, Germany), 22(49), 17552-17556. https://doi.org/10.1002/chem.201603979
Farre, Albert, et al. "Amine Catalysis for the Organocatalytic Diboration of Challenging Alkenes." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 22,49 (2016): 17552-17556. doi: https://doi.org/10.1002/chem.201603979
Farre A, Soares K, Briggs RA, Balanta A, Benoit DM, Bonet A. Amine Catalysis for the Organocatalytic Diboration of Challenging Alkenes. Chemistry. 2016 Dec 05;22(49):17552-17556. doi: 10.1002/chem.201603979. Epub 2016 Oct 26. PMID: 27723203.
Copy Download .nbib Format: NLM
Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma.

Journal of patient-reported outcomes

Gelhorn HL, Eremenco S, Skalicky AM, Balantac Z, Cimms T, Halling K, Sexton C.
PMID: 29749970
J Patient Rep Outcomes. 2017;2(1):16. doi: 10.1186/s41687-018-0039-4. Epub 2018 Mar 27.

BACKGROUND: The Brief Pain Inventory-short form (BPI-sf) is widely used in self-reported pain assessment, incorporates pain numeric rating scales (NRS) and is commonly utilized in electronic format in clinical trials, however, there is no published information about its usability...

Cite
Gelhorn HL, Eremenco S, Skalicky AM, et al. Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma. J Patient Rep Outcomes. 2018;2(1):16doi: 10.1186/s41687-018-0039-4.
Gelhorn, H. L., Eremenco, S., Skalicky, A. M., Balantac, Z., Cimms, T., Halling, K., & Sexton, C. (2017). Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma. Journal of patient-reported outcomes, 2(1), 16. https://doi.org/10.1186/s41687-018-0039-4
Gelhorn, Heather L, et al. "Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma." Journal of patient-reported outcomes vol. 2,1 (2017): 16. doi: https://doi.org/10.1186/s41687-018-0039-4
Gelhorn HL, Eremenco S, Skalicky AM, Balantac Z, Cimms T, Halling K, Sexton C. Content validity and ePRO usability of the BPI-sf and "worst pain" item with pleural and peritoneal mesothelioma. J Patient Rep Outcomes. 2017;2(1):16. doi: 10.1186/s41687-018-0039-4. Epub 2018 Mar 27. PMID: 29749970; PMCID: PMC5934933.
Copy Download .nbib Format: NLM
Construction of multiple, contiguous quaternary stereocenters in acyclic molecules by lithiation-borylation.

Journal of the American Chemical Society

Watson CG, Balanta A, Elford TG, Essafi S, Harvey JN, Aggarwal VK.
PMID: 25469619
J Am Chem Soc. 2014 Dec 17;136(50):17370-3. doi: 10.1021/ja509029h. Epub 2014 Dec 03.

Lithiation of carbamates followed by borylation provides a powerful method for the homologation of boron reagents. However, when applied to hindered systems (secondary carbamates with tBu-boronic esters) for the construction of two quaternary centers, this methodology fails. Instead, using...

Cite
Watson CG, Balanta A, Elford TG, et al. Construction of multiple, contiguous quaternary stereocenters in acyclic molecules by lithiation-borylation. J Am Chem Soc. 2014;136(50):17370-3doi: 10.1021/ja509029h.
Watson, C. G., Balanta, A., Elford, T. G., Essafi, S., Harvey, J. N., & Aggarwal, V. K. (2014). Construction of multiple, contiguous quaternary stereocenters in acyclic molecules by lithiation-borylation. Journal of the American Chemical Society, 136(50), 17370-3. https://doi.org/10.1021/ja509029h
Watson, Charlotte G, et al. "Construction of multiple, contiguous quaternary stereocenters in acyclic molecules by lithiation-borylation." Journal of the American Chemical Society vol. 136,50 (2014): 17370-3. doi: https://doi.org/10.1021/ja509029h
Watson CG, Balanta A, Elford TG, Essafi S, Harvey JN, Aggarwal VK. Construction of multiple, contiguous quaternary stereocenters in acyclic molecules by lithiation-borylation. J Am Chem Soc. 2014 Dec 17;136(50):17370-3. doi: 10.1021/ja509029h. Epub 2014 Dec 03. PMID: 25469619.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries